IL6 and neoplasm: The underlying mechanism proved that miR-370-3p could reduce tumor-related inflammatory factors, such as TNF-α, IL-1 β, and IL-6, thereby inhibiting proteins such as P53, β-catenin, and ki67, which are closely related to tumor growth [67].